We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

BONE MINERAL DENSITY TEST A BMD test can tell you whether or not you have osteoporosis Why Should I Get Tested? A risk factor assessment is an important first step […]

Work with us Careers Osteoporosis Canada (OC), a registered charity, is the only national organization providing services to people who have, or are at risk for, osteoporosis. OC is a […]

Osteoporosis is a common but often overlooked disease in men – a broken bone may be the first sign you have it. Often, osteoporosis in men can be secondary to […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

IMPACT REPORT 2020 – 2021 __________   PATIENT STORYJOYCE CRAWFORD Joyce’s father had osteoporosis and even though her grandmother wasn’t formally diagnosed, she had signs of the disease including her […]

Media Release Osteoporosis Canada and the International Osteoporosis Foundation underline their shared goal of improving clinical outcomes and preventing recurrent fractures in patients who have sustained fractures due to osteoporosis. […]

PARATHYROID HORMONE (PTH) A new class of osteoporosis treatments called bone formation agents Parathyroid hormone analogues belong to a class of osteoporosis medications which can promote bone growth. In Canada, […]

LONG TERM CARE Long Term Care Video Series Osteoporosis Canada, Ontario Osteoporosis Strategy, University of Waterloo and GERAS Centre for Aging Research are excited to announce the launch of four […]